Recruiting
Ovarian endometrioid carcinoma
RecruitingA Study Testing TUB-040 Combined with Standard Cancer Drugs for Patients with High-Grade Epithelial Serous or Endometrioid Ovarian Cancer
InvestigationalNo placebo
A Study Testing TUB-040 Combined with Standard Cancer Drugs for Patients with High-Grade Epithelial Serous or Endometrioid Ovarian Cancer
InvestigationalNo placebo
- Disease:Ovarian endometrioid carcinoma
- Substances:TUB-040
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:TUB-040
- Sponsor:Gilead Sciences Inc.
